Steroid/thyroid receptor-like proteins with oncogenic potential: a review

M Sluyser1

  • 1Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam.

Cancer Research
|February 1, 1990
PubMed

Insights

Mutated steroid/thyroid receptors can act as oncogenes, termed "dononcs," by disrupting normal gene transcription. These aberrant proteins may also cause tumors to lose hormonal responsiveness during progression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Certain members of the steroid/thyroid receptor superfamily can exhibit oncogenic potential when mutated or truncated.
  • Aberrant receptor forms interfere with normal transcriptional control by competing for DNA binding sites.

Purpose of the Study:

  • To introduce and define the term "dononcs" for oncogenes arising from dominant-negative mutations.
  • To explore the potential role of these "dononcs" in tumor progression and loss of hormonal responsiveness.

Main Methods:

  • Conceptual analysis of receptor function and mutation.
  • Comparison with recessive oncogenes (e.g., retinoblastoma).

Main Results:

  • Mutated/truncated receptors can function as dominant-negative oncogenes ("dononcs").
  • "Dononcs" disrupt normal transcription by interfering with DNA binding of normal receptors.
  • These oncogenes may contribute to acquired hormone resistance in tumors.

Conclusions:

  • Dominant-negative mutations in steroid/thyroid receptors can create oncogenes ("dononcs").
  • "Dononcs" represent a distinct class of oncogenes with implications for cancer development and treatment resistance.

Related Concept Videos

Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...